{"id":"CHEMBL1126","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"FCPVYOBCFFNJFS-LQDWTQKMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN G SODIUM","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Penicillin g sodium"],"synonyms":["Benzylpenicillin sodium","E706","NSC-402815","Penicillin G Sodium","Penicillin g sodium","Penicillin g sodium salt","Penicillin g sodium, crystalline"],"crossReferences":{"DailyMed":["penicillin%20g%20sodium"],"PubChem":["11112931"],"chEBI":["51765"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and has 1 investigational indication."}
{"id":"CHEMBL114070","canonicalSmiles":"O=[N+]([O-])c1cccc([N+](=O)[O-])c1","inchiKey":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINITROPHENYLENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,3 Dinitrobenzene","1,3-Dinitro-Benzene"],"crossReferences":{"PubChem":["144204670","144213993","17388932","26752980"],"drugbank":["DB02680"],"chEBI":["51397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160965","canonicalSmiles":"N[C@@H](Cc1ccccc1)C(=O)NCCOCCOCCNC(=O)c1ccc(S(N)(=O)=O)cc1","inchiKey":"QNZDHHNWUXIYOH-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07710"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl","inchiKey":"WOFMFGQZHJDGCX-ZULDAHANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOMETASONE FUROATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asmanex","Asmanex hfa","Asmanex twisthaler","Elocon","Mometasone furoate","Nasonex","Sinuva"],"synonyms":["LYR-210","LYR210","Lyr-210","Mometasone","Mometasone furoate","Mometasone furoate monohydrate","Nasonex","SCH 32088","SCH-32088"],"crossReferences":{"DailyMed":["mometasone%20furoate"],"PubChem":["144204256","170464666","56463118"],"Wikipedia":["Mometasone_furoate"],"drugbank":["DB14512"],"chEBI":["47564"]},"count":21,"approvedIndications":["EFO_0005854","HP_0006536","EFO_0000270","EFO_0000701","HP_0001742","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0007486","EFO_1001104","Orphanet_232","EFO_1001494","MONDO_0007254","EFO_1001919","MONDO_0043771","EFO_0000274","EFO_1002030","EFO_0000676","EFO_0002460","EFO_0004208","EFO_1001417","EFO_0005854","EFO_0000701","EFO_1000024","EFO_1002029","HP_0001742","EFO_0007187","EFO_0004232","HP_0006536","MONDO_0100096","EFO_1000391","EFO_0000270","EFO_0000341","EFO_0003918","EFO_0003956","EFO_0003785","EFO_0007415"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 6 approved and 15 investigational indications."}
{"id":"CHEMBL1183627","canonicalSmiles":"NCCC(=O)NCCSSCCNC(=O)CCN","inchiKey":"WELIVEBWRWAGOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALETHINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alethine","Beta alethine"],"crossReferences":{"drugbank":["DB05800"]},"childChemblIds":["CHEMBL308230"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL119","canonicalSmiles":"COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC","inchiKey":"NOYPYLRCIDNJJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETREXATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CI-898","Neutrexin","Trimetrexate"],"crossReferences":{"PubChem":["26755046","50110873"],"Wikipedia":["Trimetrexate"],"drugbank":["DB01157"]},"childChemblIds":["CHEMBL2218878","CHEMBL3392303","CHEMBL2358886"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993."}
{"id":"CHEMBL1193948","canonicalSmiles":"CCOC(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2","inchiKey":"RDJQCOBTKKAQAH-FPOVZHCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIBEGRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amibegron","SR-58611","SR58611"],"crossReferences":{"drugbank":["DB05395"]},"childChemblIds":["CHEMBL545437"],"count":4,"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0005230"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1200596","canonicalSmiles":"Oc1c(Cl)cc(Cl)c2cccnc12","inchiKey":"WDFKMLRRRCGAKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROXINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capitrol"],"synonyms":["Chloroxine"],"crossReferences":{"PubChem":["144205047","170465084","174006956","24715093","24715133","24813759","26749233"],"Wikipedia":["Chloroxine"],"drugbank":["DB01243"],"chEBI":["59477"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1200681","canonicalSmiles":"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)[O-])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1.[Na+]","inchiKey":"LBFBRXGCXUHRJY-HKHDRNBDSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"MONTELUKAST SODIUM","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL787","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Montelukast sodium","Singulair"],"synonyms":["MK-476","Montelukast monosodium salt","Montelukast sodium"],"crossReferences":{"DailyMed":["montelukast%20sodium"],"PubChem":["144205750","170465230","56320471"],"chEBI":["6993"]},"count":8,"approvedIndications":["EFO_0005854","EFO_0000270","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000173198"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0008521","EFO_0007183","EFO_0010638","HP_0011950","EFO_0009836","EFO_0004232","HP_0040187","EFO_0000270","EFO_0000341","EFO_1001417","EFO_0003918","EFO_0005672","EFO_0003956"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200690","canonicalSmiles":"NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"BJFIDCADFRDPIO-DZCXQCEKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LYPRESSIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diapid"],"synonyms":["L-8","Lypressin"],"crossReferences":{"PubChem":["144206455","144206977"],"drugbank":["DB14642"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201016","canonicalSmiles":"COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)[C@@H](NC(=O)/C(=N\\OC)c3csc(N)n3)[C@H]2SC1","inchiKey":"LTINZAODLRIQIX-FBXRGJNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPODOXIME PROXETIL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Banan","Cefpodoxime proxetil","Vantin"],"synonyms":["CS-807","Cefpodoxime proxetil","U-76252"],"crossReferences":{"DailyMed":["cefpodoxime%20proxetil"],"PubChem":["144206928","144206978"],"chEBI":["3505"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and has 1 investigational indication."}
{"id":"CHEMBL1201048","canonicalSmiles":"CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"NOTIQUSPUUHHEH-UXOVVSIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROMOSTANOLONE PROPIONATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Drolban","Masteril"],"synonyms":["32379","Dromostanolone propionate","Drostanolone","Drostanolone propionate"],"crossReferences":{"drugbank":["DB14655"],"chEBI":["31523"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201100","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O=S(=O)(O)O","inchiKey":"AKYHKWQPZHDOBW-DSXUQNDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GNF-Pf-506","maximumClinicalTrialPhase":0,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-506"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201217","canonicalSmiles":"CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1","inchiKey":"BZEWSEKUUPWQDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DYCLONINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dyclonine"],"crossReferences":{"DailyMed":["dyclonine%20hydrochloride"],"PubChem":["11112403","50100427"],"Wikipedia":["Dyclonine"],"drugbank":["DB00645"],"chEBI":["4724"]},"childChemblIds":["CHEMBL1200478"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201290","canonicalSmiles":"[K]","inchiKey":"ZLMJMSJWJFRBEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Potassium"],"crossReferences":{"chEBI":["26216"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1201470","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCODONE POLISTIREX","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1457","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocodone polistirex"],"crossReferences":{"DailyMed":["hydrocodone%20polistirex"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1201483","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOEPHEDRINE POLISTIREX","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1590","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pseudo-12"],"synonyms":["Pseudoephedrine polistirex"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1222151","canonicalSmiles":"CCCCCCCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"HEGSGKPQLMEBJL-MBJXGIAVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Octyl Beta-D-Galactoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octyl Beta-D-Galactoside"],"crossReferences":{"drugbank":["DB07924"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229868","canonicalSmiles":"O=C(NO)C1(S(=O)(=O)c2ccc(Oc3ccc(C(F)(F)F)cc3)cc2)CCOCC1","inchiKey":"FOSWRYKPHVPIDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-77774","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-77774"],"crossReferences":{"drugbank":["DB06945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230001","canonicalSmiles":"O=C(O)c1ccccc1NC(=O)N1CCC(c2ccccc2C(F)(F)F)CC1","inchiKey":"MEAQCLPMSVEOQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06985"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231469","canonicalSmiles":"O=C1Nc2ccc(Br)cc2/C1=C1/Nc2ccccc2C1=O","inchiKey":"IEQQJQHHJMQETK-YPKPFQOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231469","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["534343"],"drugbank":["DB07493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232993","drugType":"Small molecule","blackBoxWarning":false,"name":"GADOLINIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gadolinium"],"crossReferences":{"chEBI":["33375"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1234593","canonicalSmiles":"CC(C)c1nc2c(OCC3CCCCC3)nc(N)nc2[nH]1","inchiKey":"JABXNQUXGJTKRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234593","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08247"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235140","canonicalSmiles":"C[C@@]1(O)OC[C@H](O)C1(O)O","inchiKey":"BVIYGXUQVXBHQS-IUYQGCFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235140","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04346"],"chEBI":["44800"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235246","canonicalSmiles":"CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O","inchiKey":"HVAUUPRFYPCOCA-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235246","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26754980","26754981"],"drugbank":["DB02261"],"chEBI":["44811"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236183","canonicalSmiles":"O=C(CO)[C@@H](O)[C@@H](O)[C@H](O)CO","inchiKey":"BJHIKXHVCXFQLS-PQLUHFTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAGATOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-tagatose","Tagatose"],"crossReferences":{"drugbank":["DB04936"],"chEBI":["47693"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1254709","canonicalSmiles":"Clc1ccc2c(NCCCN3CCC(NC(c4ccccn4)c4ccccn4)CC3)ccnc2c1","inchiKey":"QRCZXFIANKOFOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DM-1157","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DM1157","Dm-1157","Dm1157","PL-69","PL69"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1255735","canonicalSmiles":"N=C(N)N1CCc2ccccc2C1.O=S(=O)(O)O","inchiKey":"SVYNLIRHKQCPNE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Debrisoquin Sulfate","maximumClinicalTrialPhase":0,"parentId":"CHEMBL169901","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Debrisoquin Sulfate"],"crossReferences":{"PubChem":["855893"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255891","canonicalSmiles":"CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1","inchiKey":"RICZEKWVNZFTNZ-LFGITCQGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARLAPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Narlaprevir","SCH 900518","SCH-900518"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1257022","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.Cl","inchiKey":"NUXLENPAZQNFAM-FFHNEAJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Methoxy-Morphanin HCl","maximumClinicalTrialPhase":0,"parentId":"CHEMBL485","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Methoxy-Morphanin HCl"],"crossReferences":{"PubChem":["144206437"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1272","canonicalSmiles":"CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O","inchiKey":"FAEKWTJYAYMJKF-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPAGLINIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enyglid","Novonorm","Prandin","Repaglinide"],"synonyms":["A10BX02","AG-EE 623 ZW","AG-EE-623-ZW","AG-EE-623ZW","AGEE-623ZW","Prandin","Repaglinide"],"crossReferences":{"DailyMed":["repaglinide"],"PubChem":["11112894","144204272","26719812","49648522"],"Wikipedia":["Repaglinide"],"drugbank":["DB00912"],"chEBI":["8805"]},"count":7,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0003914","Orphanet_68380","HP_0003124","EFO_0002508","EFO_0001645","Orphanet_44890","Orphanet_586","EFO_0001360","EFO_0000400","MONDO_0008315","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for type ii diabetes mellitus and diabetes mellitus and has 5 investigational indications."}
{"id":"CHEMBL1284","canonicalSmiles":"O=C(O)Cc1ccc(O)c(O)c1","inchiKey":"CFFZDZCDUFSOFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4-DIHYDROXYPHENYLACETIC ACID ","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DOPAC"],"crossReferences":{"PubChem":["11111112","124879971","26732626","26753554","50106188","85231019","90341470"],"Wikipedia":["3,4-Dihydroxyphenylacetic_acid"],"drugbank":["DB01702"],"chEBI":["41941"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1287935","canonicalSmiles":"CC[C@H](Nc1cc(C)nc2c(-c3ccc(OC)cc3C)c(C)nn12)c1nc(C)no1","inchiKey":"VKHVAUKFLBBZFJ-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERUCERFONT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-561,679","GSK-561679","GSK-561679A","GSK561679","GSK561679A","NBI-77860","Verucerfont"],"crossReferences":{"drugbank":["DB12512"]},"count":6,"linkedTargets":{"rows":["ENSG00000120088"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0000555","EFO_0001358","EFO_1001917","Orphanet_418","EFO_0003829"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL130880","canonicalSmiles":"Nc1c2c(nc3c1CCC3)CCCC2","inchiKey":"YLUSMKAJIQOXPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPIDACRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipidacrine"],"crossReferences":{"PubChem":["26719760"],"drugbank":["DB13668"]},"childChemblIds":["CHEMBL1898637"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1393","canonicalSmiles":"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21","inchiKey":"LXMSZDCAJNLERA-ZHYRCANASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SPIRONOLACTONE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abbolactone","Aldactone","Carospir","Diatensec","Gx spironol","Laractone","Spiretic","Spiroctan 100","Spiroctan 25","Spiroctan 50","Spironolactone","Spirospare 100","Spirospare 25"],"synonyms":["NSC-150399","SC-9420","Spironolactone"],"crossReferences":{"DailyMed":["spironolactone"],"PubChem":["144206598","144212471","26757816","47193741"],"Wikipedia":["Spironolactone"],"drugbank":["DB00421"],"chEBI":["9241"]},"count":29,"approvedIndications":["EFO_0003144","EFO_0004255","EFO_0000373","EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["HP_0001397","EFO_0001361","EFO_1000710","MONDO_0100130","EFO_0000275","EFO_0001365","EFO_0000401","EFO_1001249","EFO_0000373","EFO_1002048","EFO_0000565","EFO_0003914","EFO_0008585","EFO_0003144","EFO_0003884","MONDO_0000088","EFO_0004255","EFO_0004616","EFO_1002032","EFO_0000400","EFO_0008586","EFO_1000802","EFO_0000694","EFO_0000616","MONDO_0005149","EFO_0003963","HP_0001919","EFO_0000222","EFO_0000319","EFO_0003894","EFO_1001496","EFO_0000660","EFO_0000311","EFO_0000537","Orphanet_98896","EFO_0004517","MONDO_0100096","EFO_1001482","HP_0004308","EFO_0000574","EFO_1001207","EFO_1000766","HP_0001943","EFO_0000612","HP_0012424","EFO_0003918","EFO_0004191","EFO_1000899"],"count":48},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 5 approved and 24 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1406148","canonicalSmiles":"CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC","inchiKey":"VLPFTAMPNXLGLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICAPRILIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC-1202","AC-1204","CER-0001","NSC-4059","Tricaprilin"],"crossReferences":{"PubChem":["144204661","144208678","144213079","170465841","17389701","85148784"],"drugbank":["DB12176"],"chEBI":["76978"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL145347","canonicalSmiles":"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)[C@H]1O[C@](CC)([C@H]2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C","inchiKey":"BBMULGJBVDDDNI-OWKLGTHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LASALOCID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lasalocid","RO 2-2985"],"crossReferences":{"Wikipedia":["Lasalocid"],"drugbank":["DB11423"]},"childChemblIds":["CHEMBL1489769"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1455","canonicalSmiles":"CN(C)c1nc(N(C)C)nc(N(C)C)n1","inchiKey":"UUVWYPNAQBNQJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALTRETAMINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hexalen","Hexastat"],"synonyms":["Altretamine","Hexamethylmelamine","NSC-13875"],"crossReferences":{"PubChem":["11110789","11110790","144203636","144209982","170464714","174006220","50103890","56422107","78208","85230922","855523","90341558"],"Wikipedia":["Altretamine"],"drugbank":["DB00488"],"chEBI":["24564"]},"count":3,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for neoplasm and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1482","canonicalSmiles":"CC(C[N+](C)(C)C)OC(N)=O","inchiKey":"NZUPCNDJBJXXRF-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"BETHANECHOL","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bethanechol"],"crossReferences":{"DailyMed":["bethanechol%20chloride"],"PubChem":["124879661","26756574","90341349"],"Wikipedia":["Bethanechol"],"drugbank":["DB01019"],"chEBI":["3084"]},"childChemblIds":["CHEMBL1768"],"count":3,"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0004232","EFO_0002618","EFO_0001360"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 3 investigational indications."}
{"id":"CHEMBL1510","canonicalSmiles":"CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12","inchiKey":"PWVXXGRKLHYWKM-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELETRIPTAN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Relpax"],"synonyms":["Eletriptan","UK-116,044","UK-116,044-04 FREE BASE","UK-116,044-04 [AS HYDROBROMIDE)","UK-116044","UK-116044-04","UK-116044-04 FREE BASE"],"crossReferences":{"DailyMed":["eletriptan%20hydrobromide"],"PubChem":["144206290","170465317","50125841"],"Wikipedia":["Eletriptan"],"drugbank":["DB00216"],"chEBI":["50922"]},"childChemblIds":["CHEMBL1201003"],"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546","ENSG00000179097"],"count":3},"linkedDiseases":{"rows":["EFO_0005296","EFO_0003821","EFO_0005295"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL151958","canonicalSmiles":"Cc1c(CNc2cccc3ncccc23)cnc2nc(N)nc(N)c12","inchiKey":"KMSATRJZEXNGDP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL151958","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03351"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL153057","canonicalSmiles":"CCCc1c(OCCCOc2ccc(OCC(=O)O)cc2)ccc(C(C)=O)c1O","inchiKey":"HBBVCKCCQCQCTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-165041","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-165041"],"crossReferences":{"PubChem":["11111371","124880537","144212730","26753592","50106426","50106427","56463274","85231109","90341011"],"drugbank":["DB08078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1608558","canonicalSmiles":"CN=C=O","inchiKey":"HAMGRBXTJNITHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1608558","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208258","17388916"],"drugbank":["DB12765"],"chEBI":["59059"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1628234","canonicalSmiles":"CN(C)CCC=C1c2ccccc2COc2ccccc21.Cl","inchiKey":"MHNSPTUQQIYJOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXEPIN HYDROCHLORIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1628227","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adapin","Doxepin hydrochloride","Quitaxon","Silenor","Sinequan","Xepin","Zonalon"],"synonyms":["Doxepin hydrochloride","NSC-108160","P-3693A"],"crossReferences":{"DailyMed":["doxepin%20hydrochloride"],"PubChem":["26719773","26748009"]},"count":2,"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0003843","EFO_1001904"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1650456","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O.O=C(O)C(F)(F)F","inchiKey":"RPRCIXKRLHWPJO-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1650456","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1650443","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1652442","canonicalSmiles":"Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"OAKKJVUSSVZQRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAQUINE TETRAPHOSPHATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL303933","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piperaquine Phosphate","Piperaquine tetraphosphate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL168815","canonicalSmiles":"CC1OC2(CS1)CN1CCC2CC1","inchiKey":"WUTYZMFRCNBCHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEVIMELINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cevimeline"],"crossReferences":{"DailyMed":["cevimeline%20hydrochloride"]},"childChemblIds":["CHEMBL2218917"],"count":1,"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0009869"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000 and has 1 investigational indication."}
{"id":"CHEMBL1697845","canonicalSmiles":"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"ZDHCJEIGTNNEMY-XGXHKTLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORETHANDROLONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-70581","Norethandrolone"],"crossReferences":{"drugbank":["DB12787"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1715705","canonicalSmiles":"Cl.O.O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1","inchiKey":"OWIZTYOMGVTSDP-TXOOBNKBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1715705","maximumClinicalTrialPhase":0,"parentId":"CHEMBL11662","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576971"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743047","drugType":"Antibody","blackBoxWarning":true,"name":"NECITUMUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["11F8","IMC-11F8","Necitumumab"],"crossReferences":{"DailyMed":["necitumumab"],"DrugCentral":["5071"]},"count":5,"approvedIndications":["EFO_0000616","EFO_0003060"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000708","EFO_0000707","EFO_0003060","EFO_0009708"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for non-small cell lung carcinoma and neoplasm and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1751","canonicalSmiles":"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O","inchiKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGOXIN","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Digamex","Digoxin","Digoxin pediatric","Lanoxicaps","Lanoxin","Lanoxin pediatric","Lanoxin-125","Lanoxin-pg","Vanoxin"],"synonyms":["Digoxin","NSC-95100"],"crossReferences":{"DailyMed":["digoxin"],"PubChem":["11533002","144204576","144208876","144213367","17389540","26752810","49718191","50105460","56422204"],"Wikipedia":["Digoxin"],"drugbank":["DB00390"],"chEBI":["4551"]},"count":34,"approvedIndications":["EFO_0000275","EFO_0003144","EFO_0000373","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000163399","ENSG00000018625","ENSG00000105409","ENSG00000132681"],"count":4},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000558","EFO_0000275","MONDO_0002009","EFO_0000756","MONDO_0007254","EFO_1001249","EFO_0000373","Orphanet_91378","Orphanet_892","EFO_1000044","EFO_0000474","MONDO_0002050","HP_0004755","EFO_0003144","EFO_1002032","EFO_0003047","EFO_0000400","EFO_0000198","EFO_0000616","EFO_0002618","EFO_0000685","EFO_0006859","EFO_0006911","Orphanet_238557","EFO_0000222","EFO_0000319","EFO_0003060","MONDO_0008315","MP_0001845","EFO_0003890","EFO_0000764","EFO_0007328","EFO_0001360","EFO_0001062"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 4 approved and 30 investigational indications."}
{"id":"CHEMBL1767407","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)O2)c(=O)n1.[Na+].[Na+].[Na+].[Na+]","inchiKey":"PASYJVRFGUDDEW-WMUGRWSXSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"DENUFOSOL TETRASODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL507282","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denufosol tetrasodium","Denufosol tetrasodium salt","INS-37217","INS37217"],"count":4,"linkedTargets":{"rows":["ENSG00000175591"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","Orphanet_586","EFO_0005773","EFO_1001417"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL177","canonicalSmiles":"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O","inchiKey":"LKCWBDHBTVXHDL-RMDFUYIESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMIKACIN","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amikacin","Amikin","BAY 41-6551","NSC-177001"],"crossReferences":{"DailyMed":["amikacin%20sulfate"],"PubChem":["144204752","170465345","29215141"],"Wikipedia":["Amikacin"],"drugbank":["DB00479"],"chEBI":["2637"]},"childChemblIds":["CHEMBL1879513","CHEMBL4208954","CHEMBL4303360","CHEMBL1164318"],"count":11,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for bacterial disease and eye infection and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL178862","canonicalSmiles":"COc1ccc(-c2cc(=S)ss2)cc1","inchiKey":"KYLIZBIRMBGUOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANETHOLTRITHION","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anethole Trithione","Anethole trithione","Anetholtrithion"],"crossReferences":{"PubChem":["144206028","170465669","50112725"],"Wikipedia":["Anethole_trithione"],"drugbank":["DB13853"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180071","canonicalSmiles":"Oc1ccc(-n2nc3ccc(O)cc3c2Cl)cc1","inchiKey":"ZNHQDSBJVFFIAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180071","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07708"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180672","canonicalSmiles":"CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N","inchiKey":"PZUJQWHTIRWCID-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NPS-2143","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NPS-2143","SB-262470"],"crossReferences":{"drugbank":["DB05695"]},"childChemblIds":["CHEMBL2112075"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL184238","canonicalSmiles":"NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1","inchiKey":"ROFVXGGUISEHAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URB-597","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KDS-4103","ORG-231295","URB 597","URB597","Urb-597"],"crossReferences":{"PubChem":["174007488","29217673","47204541"],"Wikipedia":["URB597"]},"childChemblIds":["CHEMBL2314117"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1899143","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.Cl.O","inchiKey":"SGVZDMWHXVXUBY-HZQSTTLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1899143","maximumClinicalTrialPhase":0,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56320921"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189963","canonicalSmiles":"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O","inchiKey":"AHJRHEGDXFFMBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALBOCICLIB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ibrance"],"synonyms":["PD-0332991","Palbociclib"],"crossReferences":{"DailyMed":["palbociclib"],"PubChem":["103905660","103905661","137275973"],"drugbank":["DB09073"],"chEBI":["85993"]},"childChemblIds":["CHEMBL2364621","CHEMBL3962672"],"count":39,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003869","EFO_0000756","MONDO_0007254","EFO_1001469","EFO_0000708","EFO_0004252","EFO_0005952","EFO_0000228","EFO_0000305","EFO_0000632","Orphanet_178","MONDO_0008903","EFO_0000182","EFO_0008528","EFO_0002626","EFO_0000707","EFO_1000045","EFO_0000616","EFO_0002618","Orphanet_145","EFO_0006859","EFO_0006318","EFO_0000220","MONDO_0008170","EFO_0000222","EFO_1001968","MONDO_0004379","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_0000630","EFO_0000174","EFO_0002517","MONDO_0011962","EFO_0000574","EFO_0001378","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0000519","EFO_1001950","EFO_0000569"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 approved and 34 investigational indications."}
{"id":"CHEMBL1911126","canonicalSmiles":"CS(=O)(=O)O.Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21","inchiKey":"QLOMOCQVLMCSTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1911126","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1879463","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL195393","canonicalSmiles":"Nc1ncccc1OCc1cccc2ccccc12","inchiKey":"SZANYTFSQVBOBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL195393","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200435","canonicalSmiles":"CN(CCOc1ccc(-c2ccc(C#N)cc2)cc1)C(=O)NO","inchiKey":"GVMUNGGWXRKCEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200435","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06971"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL202932","canonicalSmiles":"COc1ccc(-c2ccc(S(=O)(=O)N[C@@H](C(C)C)P(=O)(O)O)cc2)cc1","inchiKey":"BZVYQWLRCHLAGK-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202932","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07772"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2029988","canonicalSmiles":"COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC","inchiKey":"DKNUPRMJNUQNHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-32496","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB-024","AC-013773","Agerafenib","CEP-32496","Cep-32496","RXDX-105","Rxdx 105"],"crossReferences":{"drugbank":["DB15068"]},"childChemblIds":["CHEMBL3309923"],"count":1,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000165731","ENSG00000157764"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL207197","canonicalSmiles":"NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N2Cc3ccccc3NC2=O)CC1)C(=O)N1CCN(c2ccncc2)CC1","inchiKey":"ITIXDWVDFFXNEG-JHOUSYSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLCEGEPANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIBN 4096 BS","BIBN-4096 BS","BIBN-4096BS","Bibn 4096 bs","Bibn-4096bs","Olcegepant"],"crossReferences":{"drugbank":["DB04869"]},"count":1,"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104514","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"RVEWUBJVAHOGKA-WOYAITHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGININE GLUTAMATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Modumate"],"synonyms":["Arginine glutamate","L-arginine l-glutamate hydrate","NSC-122009"],"crossReferences":{"DrugCentral":["4358"],"drugbank":["DB13207"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2104605","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(CSCC(F)(F)F)NS2(=O)=O","inchiKey":"RINBGYCKMGDWPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPITHIAZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epithiazide","Epitizide","P-2105"],"crossReferences":{"drugbank":["DB13989"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105294","canonicalSmiles":"COc1ccc2[n-]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Na+]","inchiKey":"RYXPMWYHEBGTRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMEPRAZOLE SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1503","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Losec sodium"],"synonyms":["H 168/68 SODIUM","Omeprazole sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105748","canonicalSmiles":"COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1.O=C(O)CCC(=O)O","inchiKey":"QZRSNVSQLGRAID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUCALOPRIDE SUCCINATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL117287","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Motegrity","Resolor"],"synonyms":["Prucalopride succinate","R-108512"],"crossReferences":{"DailyMed":["prucalopride%20succinate"]},"count":1,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["HP_0002019"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for constipation."}
{"id":"CHEMBL2105845","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CCOC(=O)[C@@H](N)C(C)C)Cn1cnc2c(=O)[nH]c(N)nc21","inchiKey":"ACBSZTQIFTYFGH-IAPPQJPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALOMACICLOVIR STEARATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-174606.0","ABT-606","MIV 606","MIV-606","Valomaciclovir stearate"],"crossReferences":{"drugbank":["DB15651"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106246","canonicalSmiles":"N/N=c1/ccc(C(N)=O)n[nH]1","inchiKey":"WRYZEGZNBYOMLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDRACARBAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydracarbazine","TH-2151"],"crossReferences":{"drugbank":["DB09243"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107456","canonicalSmiles":"CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O","inchiKey":"OJZYRQPMEIEQFC-UAWLTFRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIMAPROST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Limaprost","Limaprost alfadex","Limaprost alpha-cyclodextrin clathrate"],"crossReferences":{"drugbank":["DB09211"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107815","canonicalSmiles":"CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O.OCCNCCO","inchiKey":"RHWRWEUCEXUUAV-ZSESPEEFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREPROSTINIL DIOLAMINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237119","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orenitram","Ut-15c"],"synonyms":["Treprostinil diolamin","Treprostinil diolamine","UT-15C"],"crossReferences":{"DailyMed":["treprostinil%20diolamine"]},"count":2,"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000717"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 2 investigational indications."}
{"id":"CHEMBL2108054","drugType":"Protein","blackBoxWarning":false,"name":"TADEKINIG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tadekinig alfa"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108266","drugType":"Antibody","blackBoxWarning":false,"name":"CEDELIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cedelizumab","ORTHOCLONE OKT4 A","RWJ 49004","RWJ-49004"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108583","drugType":"Protein","blackBoxWarning":false,"name":"CINTREDEKIN BESUDOTOX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cintredekin besudotox","IL-13-PE38","IL13-PE38","IL13-PE38QQR"],"count":8,"linkedTargets":{"rows":["ENSG00000131724","ENSG00000123496","ENSG00000077238"],"count":3},"linkedDiseases":{"rows":["EFO_0000630","MONDO_0015917","EFO_0000326","EFO_0002499","EFO_0002501","EFO_0003833","EFO_0000519","EFO_1000158"],"count":8},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2108888","drugType":"Enzyme","blackBoxWarning":false,"name":"AGALSIDASE BETA","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fabrazyme"],"synonyms":[".alpha.--galactosidase","Agalsidase beta","Agalsidase beta (genetical recombination)"],"crossReferences":{"DailyMed":["agalsidase%20beta"],"DrugCentral":["5018"]},"count":1,"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2003 and has 1 investigational indication."}
{"id":"CHEMBL2109065","drugType":"Unknown","blackBoxWarning":false,"name":"DROTRECOGIN ALFA (ACTIVATED)","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"year":2011},"tradeNames":["Xigris"],"synonyms":["Drotrecogin alfa","Drotrecogin alfa (activated)","LY-203638","LY203638"],"count":7,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000198734","ENSG00000185010"],"count":2},"linkedDiseases":{"rows":["HP_0100806","EFO_0006834","MONDO_0100130","EFO_0003827","EFO_0000712","EFO_0003884","EFO_1000652","HP_0004419","EFO_0005251"],"count":9},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for recurrent thrombophlebitis and has 6 investigational indications. It was withdrawn in European Union  in 2011."}
{"id":"CHEMBL2109181","drugType":"Antibody","blackBoxWarning":false,"name":"NEBACUMAB","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Spain"],"year":1993},"tradeNames":["Centoxin"],"synonyms":["CENTOXIN","HA-1A","Nebacumab","SEPTOMONAB","Septomonab"],"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 1991. It was withdrawn in United Kingdom and  Spain initially in 1993."}
{"id":"CHEMBL2109402","drugType":"Antibody","blackBoxWarning":false,"name":"MM-121","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MM-121","SAR-256212"],"count":7,"linkedTargets":{"rows":["ENSG00000065361"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002158","MONDO_0008170","MONDO_0007254","MONDO_0002087","EFO_0003060","EFO_0000311"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109567","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-564","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-564"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109573","drugType":"Antibody","blackBoxWarning":false,"name":"GSK-249320","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-249320","Gsk-249320"],"count":1,"linkedTargets":{"rows":["ENSG00000105695"],"count":1},"linkedDiseases":{"rows":["EFO_0000712"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109630","drugType":"Antibody","blackBoxWarning":false,"name":"BC8 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BC8","Bc8 131i"],"linkedTargets":{"rows":["ENSG00000081237"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000222","EFO_0001378"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2110568","drugType":"Small molecule","blackBoxWarning":false,"name":"CHROMIC PHOSPHATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL1200676"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL2111187","canonicalSmiles":"[Cl-].[Cl-].[Ra+2]","inchiKey":"RWRDJVNMSZYMDV-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"RADIUM DICHLORIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Radium dichloride"],"crossReferences":{"DailyMed":["radium%20ra-223%20dichloride"]},"childChemblIds":["CHEMBL2107816"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 investigational indications."}
{"id":"CHEMBL213661","canonicalSmiles":"OC[C@H]1CN(CCCc2ccccc2)C[C@@H](O)[C@@H]1O","inchiKey":"NKARZGURZMIRMA-RBSFLKMASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL213661","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07807"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146095","canonicalSmiles":"O=C1O[C@H]([C@@H](O)CO)C([O-])=C1O.O=C1O[C@H]([C@@H](O)CO)C([O-])=C1O.[Ca+2]","inchiKey":"BLORRZQTHNGFTI-ZZMNMWMASA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM ASCORBATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium ascorbate"],"crossReferences":{"drugbank":["DB14483"]},"childChemblIds":["CHEMBL3184533"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2204360","canonicalSmiles":"Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1.Cl","inchiKey":"JOJYHYRCIYAVHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2204360","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2104993","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2205807","canonicalSmiles":"Cc1ccc(-c2ccc(C)cn2)nc1","inchiKey":"PTRATZCAGVBFIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABAMETAPIR","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xeglyze"],"synonyms":["Abametapir","HA-44","Ha44"],"crossReferences":{"drugbank":["DB11932"]},"count":1,"approvedIndications":["MONDO_0003472"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for lice infestation."}
{"id":"CHEMBL22150","canonicalSmiles":"CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"WFNAKBGANONZEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORCYCLIZINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorcyclizine"],"crossReferences":{"Wikipedia":["Chlorcyclizine"],"drugbank":["DB08936"]},"childChemblIds":["CHEMBL1889091"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2220427","canonicalSmiles":"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C","inchiKey":"TYQXKHPOXXXCTP-CSLYCKPJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN PROPIONATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Erythromycin propionate"],"crossReferences":{"PubChem":["144206740","170465433"],"chEBI":["48913"]},"childChemblIds":["CHEMBL2218877"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967."}
{"id":"CHEMBL227529","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O.O=C(O)c1ccccc1","inchiKey":"KEJICOXJTRHYAK-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOGLIPTIN BENZOATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL376359","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nesina"],"synonyms":["Alogliptin benzoate","SYR 322","SYR-322"],"crossReferences":{"DailyMed":["alogliptin%20benzoate"],"chEBI":["72324"]},"count":1,"approvedIndications":["EFO_0001360"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013 and is indicated for type ii diabetes mellitus."}
{"id":"CHEMBL227552","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H]1O","inchiKey":"WFPZSXYXPSUOPY-ROYWQJLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227552","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01774"],"chEBI":["15751"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364627","canonicalSmiles":"CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)nc21.CS(=O)(=O)O.CS(=O)(=O)O","inchiKey":"NARMJPIBAXVUIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALIMETINIB MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2364626","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LSN2322600","LY2228820 dimesylate","Ralimetinib mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364721","canonicalSmiles":"[2H]C1([2H])CNP(=O)(N(CCCl)CCCl)OC1","inchiKey":"CMSMOCZEIVJLDB-DICFDUPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2364721","maximumClinicalTrialPhase":0,"parentId":"CHEMBL88","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2403108","canonicalSmiles":"Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1","inchiKey":"VERWOWGGCGHDQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERITINIB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zykadia"],"synonyms":["Ceritinib","LDK-378","LDK378","NVP-LDK-378-NX","NVP-LDK378-NX"],"crossReferences":{"DailyMed":["ceritinib"],"drugbank":["DB09063"],"chEBI":["78432"]},"childChemblIds":["CHEMBL4476089","CHEMBL4468931","CHEMBL4542506"],"count":13,"approvedIndications":["EFO_0000616","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000171094"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002108","EFO_0000756","EFO_1001968","EFO_0003060","EFO_0000621","EFO_0005221","EFO_0000311","EFO_1000044","EFO_0003032","EFO_0000389","EFO_0001421","MONDO_0015798","EFO_0000519"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL240355","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccc2c(c1)N(CCNC(C)=O)C(=O)C(C)(C)O2","inchiKey":"GBXSOZDYCSBLQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL240355","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07059"]},"childChemblIds":["CHEMBL4081321"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253969","canonicalSmiles":"NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1","inchiKey":"HXHAJRMTJXHJJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSI-632","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-547,632","CP-547632","CP-632","Cp-547,632","Cp-547632","OSI-632","Osi-632","PAN 90806","PAN-90806","PAN90806"],"crossReferences":{"PubChem":["103905622","137275944"],"drugbank":["DB12962"]},"count":6,"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","EFO_0001365","MONDO_0021117","MONDO_0008170","EFO_0003770","MONDO_0002087"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL257978","canonicalSmiles":"Cc1c(OCC2=NCCN2)ccc(Cl)c1NS(C)(=O)=O","inchiKey":"FOYWMEJSRSBQGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DABUZALGRON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dabuzalgron","Ro 115-1240","Ro-115-1240"],"childChemblIds":["CHEMBL2107325"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL260880","canonicalSmiles":"O=P(O)(O)C(O)(COc1cccc(-c2cccc(-c3ccccc3)c2)c1)P(=O)(O)O","inchiKey":"NWIARQRYIRVYCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[1-Hydroxy-2-(1,1':3',1''-Terphenyl-3-Yloxy)Ethane-1,1-Diyl]Bis(Phosphonic Acid)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[1-Hydroxy-2-(1,1':3',1''-Terphenyl-3-Yloxy)Ethane-1,1-Diyl]Bis(Phosphonic Acid)"],"crossReferences":{"drugbank":["DB07426"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL26424","canonicalSmiles":"CCN(CC)CCOc1ccc(Cc2ccccc2)cc1","inchiKey":"NFIXBCVWIPOYCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESMILIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tesmilifene"],"crossReferences":{"PubChem":["11113676","144204475","170466289","174007210","26751862"],"drugbank":["DB04905"]},"childChemblIds":["CHEMBL2107467"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL267447","canonicalSmiles":"CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@@H]3O","inchiKey":"NIDRYBLTWYFCFV-FMTVUPSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-CALANOLIDE A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Calanolide_A"],"drugbank":["DB04886"],"chEBI":["65552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27551","canonicalSmiles":"O=CC(Cl)(Cl)Cl","inchiKey":"HFFLGKNGCAIQMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Trichloro-Acetaldehyde","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trichloro-Acetaldehyde"],"crossReferences":{"drugbank":["DB02650"],"chEBI":["48814"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL288436","canonicalSmiles":"Cc1cc2c(cc1C1(c3ccc(C(=O)O)cn3)CC1)C(C)(C)CCC2(C)C","inchiKey":"SLXTWXQUEZSSTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL288436","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137275854"],"drugbank":["DB01941"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292687","canonicalSmiles":"O=[N+]([O-])c1ccc(Cl)c([N+](=O)[O-])c1","inchiKey":"VYZAHLCBVHPDDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINITROCHLOROBENZENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-chloro-2,4-dinitrobenzene","Dinitrochlorobenzene","NSC-6292"],"crossReferences":{"PubChem":["124892793","144209154","144213119","26757478","57260144","57264331"],"drugbank":["DB11831"],"chEBI":["34718"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL302795","canonicalSmiles":"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O","inchiKey":"LZNWYQJJBLGYLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOXICAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mobiflex"],"synonyms":["RO 12-0068","RO 12-0068/000","RO-120068000","Tenoxicam"],"crossReferences":{"PubChem":["11112804","11533043","144204217","170465677","56423650"],"drugbank":["DB00469"],"chEBI":["32192"]},"count":2,"approvedIndications":["EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 1 investigational indication."}
{"id":"CHEMBL3039596","canonicalSmiles":"CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)[O-])C(C)C.[Na+]","inchiKey":"TVTJZMHAIQQZTL-WATAJHSMSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSINOPRIL SODIUM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039598","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fosinopril sodium","Fositens","Fozitec","Monopril","Staril"],"synonyms":["Fosenopril sodium","Fosinopril sodium","SQ 28555"],"crossReferences":{"DailyMed":["fosinopril%20sodium"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991 and is indicated for hypertension. This drug has a black box warning from the FDA."}
{"id":"CHEMBL306280","canonicalSmiles":"CC[C@@]1(O)CC(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(F)c(F)cc3nc2-1","inchiKey":"LFQCJSBXBZRMTN-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLOMOTECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diflomotecan"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3088054","canonicalSmiles":"Cl.O=C(O)[C@@H]1C[C@H]2C[C@@H](Oc3cccc(Cl)c3-c3nnn[nH]3)CC[C@H]2CN1","inchiKey":"HRXJUIYTXHWYPB-CGLRNCBJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3088054","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103869","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3098771","canonicalSmiles":"CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\\CCCc2ccccc21","inchiKey":"PPGNMFUMZSAZCW-VOYUZAMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UAB-30","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-CIS-UAB30","9CUAB30","Retinoid 9cuab30","UAB-30","Uab-30","Uab30"],"crossReferences":{"drugbank":["DB12316"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137316","canonicalSmiles":"Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](OP(=O)(O)O)(C(F)(F)F)CC[C@@]21Cc1ccccc1","inchiKey":"BVXLAHSJXXSWFF-KEKPKEOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSDAGROCORAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosdagrocorat","PF-04171327"],"crossReferences":{"drugbank":["DB12198"]},"count":1,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3137336","canonicalSmiles":"Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl","inchiKey":"AXTAPYRUEKNRBA-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UPROSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2141795C","GSK2141795","GSK2141795C","Gsk-2141795","Uprosertib"],"crossReferences":{"drugbank":["DB11969"]},"count":7,"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000616","MONDO_0002974","EFO_0000756","EFO_0000222","EFO_0001378","EFO_0000305","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL314437","canonicalSmiles":"CCC1(c2cccc(O)c2)CCCCN(C)C1","inchiKey":"JLICHNCFTLFZJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPTAZINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Meptazinol"],"crossReferences":{"Wikipedia":["Meptazinol"],"drugbank":["DB13478"]},"childChemblIds":["CHEMBL1477274"],"count":1,"approvedIndications":["EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for pain."}
{"id":"CHEMBL32010","canonicalSmiles":"OC1CCCCC1","inchiKey":"HPXRVTGHNJAIIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOHEXANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclohexanol"],"crossReferences":{"PubChem":["144208679","144213120","49816808"],"Wikipedia":["Cyclohexanol"],"drugbank":["DB03703"],"chEBI":["18099"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3234035","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c([C@H]2CC(=O)[C@H]3C[C@@H]2C3(C)C)c(OC(=O)/C=C/C(=O)O)c1","inchiKey":"GSTZHANFXAKPSE-MXTREEOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3234035","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05048"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3251468","canonicalSmiles":"O=[14C]1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O","inchiKey":"ADIMAYPTOBDMTL-HKGQFRNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3251468","maximumClinicalTrialPhase":0,"parentId":"CHEMBL568","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3275586","canonicalSmiles":"CC(CN1CCN(CCOCCO)CC1)CN1c2ccccc2Sc2ccccc21","inchiKey":"MSYUMPGNGDNTIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIXYRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dixyrazine"],"crossReferences":{"drugbank":["DB13784"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301608","canonicalSmiles":"Cc1nc(NNC(=O)[C@H](CC2CCCC2)CN(O)C=O)c(F)c(N2CCN3CCOC[C@@H]3C2)n1","inchiKey":"SWHNZGMQMGFQGW-MSOLQXFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANOPEPDEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1322322B","GSK1322322","GSK1322322B","Lanopepden"],"crossReferences":{"drugbank":["DB11912"]},"childChemblIds":["CHEMBL3301616"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3305965","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1cccc(S(=O)(=O)O)c1","inchiKey":"TWQWRHIQRAZHPR-XNXCGYEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3305965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14703"]},"childChemblIds":["CHEMBL3186892"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3348846","canonicalSmiles":"COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1","inchiKey":"VRQMAABPASPXMW-HDICACEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3348846","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12247"],"chEBI":["63453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL345292","canonicalSmiles":"CCCCCCSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O","inchiKey":"HXJDWCWJDCOHDG-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL345292","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04132"],"chEBI":["27704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3526906","canonicalSmiles":"COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1","inchiKey":"XMSXOLDPMGMWTH-GZXVCZRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526906","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2104753","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544951","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04531083","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-4531083","Pf-04531083"],"count":2,"linkedTargets":{"rows":["ENSG00000185313"],"count":1},"linkedDiseases":{"rows":["HP_0012532","EFO_0010072"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545060","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"ZXBDZLHAHGPXIG-VTXLJDRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN GLUCEPTATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL532","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilotycin","Ilotycin gluceptate"],"synonyms":["Erythromycin gluceptate","Erythromycin glucoheptonate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3545243","drugType":"Small molecule","blackBoxWarning":false,"name":"AS-703988","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["As-703988","MSC-2015103B"],"count":1,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545293","drugType":"Small molecule","blackBoxWarning":false,"name":"FGF401","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fgf401"],"count":1,"linkedTargets":{"rows":["ENSG00000160867"],"count":1},"linkedDiseases":{"rows":["EFO_0000182"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545377","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2606368","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly-2606368"],"count":3,"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["MONDO_0008170","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3589904","canonicalSmiles":"COc1ccc(Cl)c(-c2ccc(NC(=O)c3ccnn3C)nc2N)c1","inchiKey":"ZRJGMDIPCQOGNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3589904","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707250","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-601927","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-601,927","Cp-601927"],"count":1,"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707324","drugType":"Antibody","blackBoxWarning":false,"name":"UTOMILUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05082566","PF-5082566","Utomilumab"],"count":9,"linkedTargets":{"rows":["ENSG00000049249"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000365","EFO_0001075","EFO_0000096","EFO_0000403","MONDO_0007254","EFO_0000196","MONDO_0018906","EFO_0000305","EFO_0000311"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3707446","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"VXBNTHRZPJLRSS-PTCSXESPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVIPANSEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GMI-1070","PF-06460031","Rivipansel"],"crossReferences":{"drugbank":["DB12778"]},"childChemblIds":["CHEMBL3833316"],"count":3,"linkedTargets":{"rows":["ENSG00000188404","ENSG00000174175","ENSG00000007908"],"count":3},"linkedDiseases":{"rows":["EFO_0003086","Orphanet_232","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL37387","canonicalSmiles":"Nc1nc(O)c(Br)c(-c2ccccc2)n1","inchiKey":"CIUUIPMOFZIWIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROPIRIMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bropirimine","U-54,461"],"crossReferences":{"PubChem":["144206218","170465913"],"drugbank":["DB04168"],"chEBI":["31307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3793226","canonicalSmiles":"O=c1ccc2ccc(F)c3c2n1C[C@H]3CN1CCC(NCc2cc3c(nn2)OCCO3)CC1","inchiKey":"SRICOHRDRMZREQ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-945237","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK945237","Gsk-945237","Gsk945237"],"crossReferences":{"drugbank":["DB15345"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3806158","canonicalSmiles":"CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1","inchiKey":"BPMMYKAHRIEVDH-VOQZNFBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986104","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986104","Bms-986104"],"crossReferences":{"drugbank":["DB15214"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3809901","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C","inchiKey":"NXUWTKIOMJSLSV-DEEZXRHXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"MMI-0100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MMI 0100","Mmi-0100"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989403","canonicalSmiles":"Cc1cc(CC(=O)[O-])n(C)c1C(=O)c1ccc(Cl)cc1.O.O.[Na+]","inchiKey":"ZJXLSCXDGPDZOL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOMEPIRAC SODIUM","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL19490","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Spain"," Germany "],"classes":["Immune system toxicity"],"year":1983},"tradeNames":["Zomax"],"synonyms":["MCN-2783-21-98","Zomepirac sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980. It was withdrawn in United States,  United Kingdom,  United States,  Spain and  Germany  initially in 1983 due to Immune system toxicity."}
{"id":"CHEMBL3989492","canonicalSmiles":"N[C@@H](Cc1cc([125I])c(Oc2cc([125I])c(O)c([125I])c2)c([125I])c1)C(=O)O","inchiKey":"XUIIKFGFIJCVMT-BNZZDVIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYROXINE I 125","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1624","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tetramet"],"synonyms":["Thyroxine i 125"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989554","canonicalSmiles":"CCCCCCCCNC(=N)NC(=N)NCc1ccc(Cl)c(Cl)c1.CCCCCCCCNC(=N)NC(=N)NCc1ccc(Cl)c(Cl)c1.Cl.Cl.O","inchiKey":"PMKCJSVTNJUCGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLANEXIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1190262","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OPB-2045","Olanexidine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989677","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"IUAXSWPNEQYKDR-GXTZACRKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HYDROCODONE BITARTRATE","yearOfFirstApproval":1943,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1457","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dicodid","Hysingla","Hysingla er","Mercodinone","Vantrela er","Zohydro er"],"synonyms":["CEP-33237","Dihydrocodeinone bitartrate","Hydrocodone bitartrate","Hydrocodone bitartrate cii","Hydrocodone bitartrate hemipentahydrate"],"crossReferences":{"DailyMed":["hydrocodone%20bitartrate"]},"count":10,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000546","EFO_0003086","EFO_0003890","EFO_0002506","HP_0012532","EFO_0001421","HP_0003419","EFO_0005611","EFO_0003843","EFO_1001250"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1943 and is indicated for pain and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989849","canonicalSmiles":"C[N+]1(CC(=O)c2ccc(-c3ccccc3)cc2)[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@H](CO)c1ccccc1)C2","inchiKey":"CSYZZFNWCDOVIM-OCTNZTSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENTONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fentonium"],"crossReferences":{"drugbank":["DB08978"]},"childChemblIds":["CHEMBL3989580"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989873","canonicalSmiles":"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccc(I)cc4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"JTZRECOPNKCRTE-MOROJQBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICLIDENOSON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALB-7208","CF101","Cf101","IB-MECA","Piclidenoson"],"count":7,"linkedTargets":{"rows":["ENSG00000282608"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_1001069","EFO_1000986","MONDO_0100096","EFO_1000906","EFO_0000676","EFO_0004616","EFO_0000516","EFO_1001119"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3989949","canonicalSmiles":"NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl","inchiKey":"GFHAXPJGXSQLPT-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENOBAMATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xcopri"],"synonyms":["Cenobamate","YKP-3089","YKP3089"],"crossReferences":{"DailyMed":["cenobamate"],"drugbank":["DB06119"]},"count":3,"approvedIndications":["HP_0001250"],"linkedTargets":{"rows":["ENSG00000153253","ENSG00000136546","ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000168356","ENSG00000166206","ENSG00000007314","ENSG00000196876","ENSG00000182256","ENSG00000102287","ENSG00000185313","ENSG00000183873","ENSG00000022355","ENSG00000144285","ENSG00000094755","ENSG00000268089","ENSG00000169432","ENSG00000163285","ENSG00000113327","ENSG00000186297","ENSG00000136531","ENSG00000163288"],"count":26},"linkedDiseases":{"rows":["EFO_0000474","EFO_0004263","HP_0001250"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for seizure and has 2 investigational indications."}
{"id":"CHEMBL3989976","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGVORHYALURONIDASE ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PEGPH-20","PEGPH20","Pegvorhyaluronidase alfa"],"count":7,"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3990044","drugType":"Antibody","blackBoxWarning":false,"name":"RELATLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986016","Relatlimab"],"count":5,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL401150","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]2C[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H]1O","inchiKey":"JIAJERGOUFOENU-LNAOLWRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401150","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03186"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL404216","canonicalSmiles":"CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21","inchiKey":"RUJBDQSFYCKFAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOFISOPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tofisopam"],"crossReferences":{"PubChem":["144205822","29217670","50111721"],"Wikipedia":["Tofisopam"],"drugbank":["DB08811"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL409450","canonicalSmiles":"O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\\O","inchiKey":"DDLZLOKCJHBUHD-WAVHTBQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6BIO","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26753605","26753606","29215160","90341740"],"drugbank":["DB03444"],"chEBI":["86290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL41194","canonicalSmiles":"CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CCCC2","inchiKey":"KCTFTBCZZUBAKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRATOSARTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA727","KT3-671","Kt-3671","Pratosartan"],"crossReferences":{"chEBI":["32041"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4128835","canonicalSmiles":"C[C@@H](N[C@H]1CCN(c2ccc(CC(=O)O)cc2)C1)c1cccc2ccccc12.Cl.Cl","inchiKey":"GGCDGPMTTKKELW-KJHBKDRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4128835","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4297621","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL413","canonicalSmiles":"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C","inchiKey":"QFJCIRLUMZQUOT-HPLJOQBZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SIROLIMUS","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rapamune","Sirolimus"],"synonyms":["AY-22989","L04AA10","NSC-226080","Rapamycin","SM-88 COMPONENT SIROLIMUS","Sirolimus","WY-090217"],"crossReferences":{"DailyMed":["sirolimus"],"PubChem":["124886754","144204421","144206303","50103901"],"Wikipedia":["Sirolimus"],"drugbank":["DB00877"],"chEBI":["9168"]},"count":111,"approvedIndications":["EFO_0003966","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["Orphanet_122","EFO_0000637","EFO_0007323","EFO_0000681","EFO_0000401","Orphanet_1059","EFO_0005952","EFO_1000653","EFO_0000339","EFO_0002690","MONDO_0008903","EFO_0003884","EFO_1000251","EFO_0000514","EFO_1000882","EFO_0008517","EFO_0000760","Orphanet_379","EFO_0000198","MONDO_0013730","EFO_0002618","MONDO_0007608","Orphanet_46724","EFO_1000811","MONDO_0005149","Orphanet_2309","EFO_1000906","EFO_0000180","EFO_0002424","Orphanet_636","EFO_1001946","EFO_1001968","EFO_1001496","EFO_0000384","MONDO_0008315","MONDO_0002691","GO_0007568","MONDO_0009453","EFO_0009259","Orphanet_2869","EFO_0000574","Orphanet_101997","EFO_0001378","MONDO_0015564","EFO_0001062","EFO_0003086","Orphanet_84","EFO_0000292","EFO_0001365","EFO_0002913","EFO_1001465","MONDO_0007254","MONDO_0016236","EFO_0003966","EFO_0006888","MONDO_0002050","MONDO_0002898","Orphanet_77260","EFO_0000196","EFO_0000183","Orphanet_447","EFO_0000616","MONDO_0019457","EFO_0001645","EFO_0000403","Orphanet_1063","EFO_0009661","EFO_0004198","EFO_0000222","EFO_0003929","EFO_0004599","EFO_0000537","Orphanet_624","MONDO_0002603","EFO_0000764","EFO_0006927","EFO_0000702","EFO_1001947","MONDO_0024880","EFO_1001927","EFO_0000519","EFO_0004265","MONDO_0000873","EFO_0004683","EFO_0001075","Orphanet_183660","EFO_0000571","EFO_1000657","Orphanet_848","MONDO_0002177","EFO_0000540","EFO_0003829","EFO_0003913","EFO_0000565","Orphanet_365","EFO_0003870","EFO_0000544","MONDO_0002280","Orphanet_733","HP_0001871","EFO_0000182","MONDO_0018531","EFO_0000253","MONDO_0019063","EFO_1000749","EFO_0008620","HP_0003124","EFO_0000220","MONDO_0002108","EFO_0004224","EFO_0002508","EFO_1001466","EFO_0004236","EFO_0004194","MONDO_0044881","EFO_1001119","EFO_0009708","MP_0001845","EFO_1000986","MONDO_0100096","EFO_0000731","EFO_0001359","MONDO_0037255","Orphanet_282","Orphanet_232","MONDO_0015686","EFO_1000475","EFO_1001469","Orphanet_538","HP_0001915","EFO_0000708","EFO_1002048","MONDO_0001187","MONDO_0001718","EFO_1001480","EFO_1000044","EFO_0006890","Orphanet_309144","Orphanet_93460","EFO_0003047","EFO_0009321","EFO_0000717","EFO_1000158","EFO_0003770","EFO_0003060","EFO_0000621","Orphanet_3205","EFO_0000311","MONDO_0001705","HP_0001626","EFO_0000095","EFO_0006475","EFO_0001421","EFO_0008583","EFO_0000691","MONDO_0021637"],"count":156},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for eye disease and immune system disease and has 109 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL419362","canonicalSmiles":"COC(=O)[C@H](Cc1ccc(C#Cc2ccccc2)cc1)NC(=O)C[C@H]1CCCN(C(=N)N)C1","inchiKey":"MRNGXYMKYHNMLV-PKTZIBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Ro-264550","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ro-264550"],"crossReferences":{"drugbank":["DB03453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4209111","canonicalSmiles":"NC(=O)Cc1ccc(Nc2cc(C(F)(F)F)nc(-c3cccc(Cl)c3)n2)cc1","inchiKey":"KRRGWHSEDYQKDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4209111","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14790"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428","canonicalSmiles":"N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12","inchiKey":"WVPSKSLAZQPAKQ-CDMJZVDBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TROVAFLOXACIN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Hepatotoxicity"],"year":1999},"tradeNames":[],"synonyms":["CP-99219","Trovafloxacin"],"crossReferences":{"Wikipedia":["Trovafloxacin"],"drugbank":["DB00685"],"chEBI":["9763"]},"childChemblIds":["CHEMBL1200779"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for bacterial disease and has 1 investigational indication. It was withdrawn in European Union and  United States initially in 1999 due to Hepatotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL428963","canonicalSmiles":"Cc1nnc(-c2ccccc2Nc2ncnc3[nH]ccc23)[nH]1","inchiKey":"OKGCSZUKOGMZAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL428963","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07584"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297229","drugType":"Unknown","blackBoxWarning":true,"name":"PRABOTULINUMTOXIN A","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jeuveau"],"synonyms":["DWP-450","DWP450","Prabotulinumtoxin a","Prabotulinumtoxina-xvfs"],"count":1,"approvedIndications":["EFO_0005422"],"linkedTargets":{"rows":["ENSG00000132639"],"count":1},"linkedDiseases":{"rows":["EFO_0005422"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for skin aging. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297271","drugType":"Small molecule","blackBoxWarning":false,"name":"BMX-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bmx-001"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297374","canonicalSmiles":"CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"NHIUKVHKLJSJEA-LINJWFRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILADEMETAN TOSYLATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4292264","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-3032 TOSYLATE","DS-3032B","Ds 3032b","Ds-3032b","Milademetan tosylate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297471","canonicalSmiles":"Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2cc3c(cn2)[C@@H]2[C@@H](C(=O)O)[C@@H]2C3)c1","inchiKey":"CODQKEMYZZKQAE-QPVYNBJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-8666","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8666","Mk-8666"],"crossReferences":{"drugbank":["DB14937"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297500","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC/C(=N\\O)[C@](C)(CCCO)[C@H]3CC[C@@]21C","inchiKey":"OBKBVSFXEIFOMS-YVABUZGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRO-40303","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRO 40303","TRO-40303","TRO40303","Tro-40303","Tro40303"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297536","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PATISIRAN SODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Onpattro"],"synonyms":["Patisiran sodium"],"crossReferences":{"DailyMed":["patisiran%20sodium"]},"count":1,"approvedIndications":["Orphanet_85447"],"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["Orphanet_85447"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for familial amyloid polyneuropathy."}
{"id":"CHEMBL4297691","drugType":"Unknown","blackBoxWarning":false,"name":"ALX-009","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alx-009"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297783","drugType":"Unknown","blackBoxWarning":false,"name":"MK-1654","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-1654","Mk-1654"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297875","drugType":"Unknown","blackBoxWarning":false,"name":"AFP-464","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AFP464","Afp 464","Afp-464","Afp464"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL444929","canonicalSmiles":"CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](NCCCNCCCCN)C[C@@H]1C[C@H]3O)OS(=O)(=O)O","inchiKey":"UIRKNQLZZXALBI-MSVGPLKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUALAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Squalamine"],"crossReferences":{"Wikipedia":["Squalamine"],"drugbank":["DB06461"],"chEBI":["80765"]},"childChemblIds":["CHEMBL3989689","CHEMBL2386601"],"linkedTargets":{"rows":["ENSG00000066230"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","EFO_0001365","MONDO_0008170","EFO_0003770","MONDO_0008315"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL448297","canonicalSmiles":"COc1cc(O)c2c(c1)O[C@H](c1ccc(O)cc1)CC2=O","inchiKey":"DJOJDHGQRNZXQQ-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAKURANETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-O-Methylnaringenin","Naringenin 7-Methyl Ether","Sakuranetin"],"crossReferences":{"Wikipedia":["Sakuranetin"],"drugbank":["DB08517"],"chEBI":["28927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594214","canonicalSmiles":"CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC3=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O","inchiKey":"BPKIMPVREBSLAJ-QTBYCLKRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ZICONOTIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prialt"],"synonyms":["SNX-111","Ziconotide"],"count":2,"approvedIndications":["HP_0001945","EFO_0003843"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for pain and fever."}
{"id":"CHEMBL4594495","drugType":"Unknown","blackBoxWarning":false,"name":"SC-006","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-006","SC006","Sc-006"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594520","drugType":"Unknown","blackBoxWarning":false,"name":"AMG-224","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 224","AMG-224","Amg 224","Amg-224"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594549","drugType":"Antibody","blackBoxWarning":false,"name":"PIMURUTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HLX-07","HLX07","Hlx07","Pimurutamab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594607","drugType":"Enzyme","blackBoxWarning":false,"name":"APADAMTASE ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apadamtase alfa","BAX-930","SHP-655","SHP655","Shp655","TAK-755"],"count":2,"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL476323","canonicalSmiles":"Cc1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1","inchiKey":"DDDZBLNULGDPGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0249","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0249","MK0249","Mk-0249"],"crossReferences":{"drugbank":["DB11910"]},"count":5,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","HP_0000726","EFO_0000249","EFO_0003918","EFO_0000692"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL480517","canonicalSmiles":"O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C/c3ccc([N+](=O)[O-])cc3[N+](=O)[O-])CS[C@H]12","inchiKey":"LHNIIDJCEODSHA-OQRUQETBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROCEFIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nitrocefin"],"crossReferences":{"drugbank":["DB11592"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL482858","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(=O)O)[C@H]2SC1","inchiKey":"HOKIDJSKDBPKTQ-GLXFQSAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOSPORIN C","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cephalosporin c"],"crossReferences":{"PubChem":["90341458"],"Wikipedia":["Cephalosporin_C"],"drugbank":["DB03313"],"chEBI":["15776"]},"childChemblIds":["CHEMBL1326149","CHEMBL3138667"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL48361","canonicalSmiles":"Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21","inchiKey":"YBSJFWOBGCMAKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DABIGATRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pradaxa"],"synonyms":["BIBR 953 ZW","BIBR-953","BIBR-953-ZW","Dabigatran"],"crossReferences":{"PubChem":["174006835"],"Wikipedia":["Dabigatran"],"drugbank":["DB14726"],"chEBI":["70752"]},"count":9,"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["HP_0001907","MP_0001914","EFO_0000546","HP_0000083","EFO_0000275","EFO_0010680","EFO_0003827","EFO_0000712","EFO_0001645","EFO_0004286","Orphanet_136","EFO_1001413","EFO_0000400"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL489799","canonicalSmiles":"O=C(NC(=O)c1ccccc1)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"JSBCZGSPFATCOV-BZNQNGANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489799","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL491429","canonicalSmiles":"O=C(Nc1cncnc1)c1c(Cl)ccc2c(Nc3cccc(C(F)(F)F)c3)noc12","inchiKey":"FEGRQUWSKADGSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL491429","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07326"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506871","canonicalSmiles":"C[C@]1(c2nc3cccc(C(N)=O)c3[nH]2)CCCN1","inchiKey":"JNAHVYVRKWKWKQ-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELIPARIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-888","PARP-1 INHIBITOR ABT-888","Veliparib"],"crossReferences":{"drugbank":["DB07232"],"chEBI":["62880"]},"count":33,"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484","ENSG00000041880"],"count":3},"linkedDiseases":{"rows":["EFO_1000412","EFO_0001075","MONDO_0015686","EFO_1001465","MONDO_0007254","EFO_1000657","EFO_0000708","EFO_0005952","EFO_1001469","EFO_0000305","EFO_0002917","EFO_1000357","EFO_1001951","MONDO_0001056","EFO_0006462","MONDO_0002158","EFO_1000044","EFO_1001480","MONDO_0015760","EFO_0003968","EFO_0000182","EFO_0002499","EFO_1000042","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0002618","EFO_0005088","Orphanet_145","EFO_0000466","MONDO_0008170","EFO_1000435","EFO_0003060","MONDO_0008315","EFO_0001663","EFO_0000311","EFO_0006772","EFO_0006861","EFO_0005537","EFO_0000702","EFO_1000252","EFO_0000574","MONDO_0024880","EFO_0000519","EFO_1000494"],"count":45},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 33 investigational indications."}
{"id":"CHEMBL50882","canonicalSmiles":"Nc1n[n+]([O-])c2ccccc2[n+]1[O-]","inchiKey":"ORYDPOVDJJZGHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRAPAZAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-259075","SR259075","Tirapazamine","WIN 59075","WIN-59075"],"crossReferences":{"Wikipedia":["Tirapazamine"],"drugbank":["DB04858"],"chEBI":["78887"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL514800","canonicalSmiles":"CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC","inchiKey":"IMOZEMNVLZVGJZ-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APREMILAST","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Otezla"],"synonyms":["Apremilast","CC-10004","CC10004"],"crossReferences":{"DailyMed":["apremilast"],"drugbank":["DB05676"],"chEBI":["78540"]},"count":23,"approvedIndications":["EFO_0000676","EFO_0003778","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000668","EFO_1001494","EFO_1000710","EFO_0003780","EFO_0004274","EFO_0003778","EFO_0000274","EFO_1000747","EFO_0000540","Orphanet_163927","EFO_0003829","EFO_0000676","EFO_0004208","EFO_1000789","EFO_1000726","EFO_0008517","EFO_0000685","MONDO_0026045","HP_0000964","MONDO_0022113","EFO_0003898","MONDO_0019558","EFO_0003894","EFO_0003106","EFO_0009855","EFO_1000760","EFO_1001231","MONDO_0100096","EFO_0000398","MONDO_0002406","EFO_0007328","EFO_0003830","HP_0011107"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 20 investigational indications."}
{"id":"CHEMBL54481","canonicalSmiles":"O=C(O)c1cc(O)c2c(c1)C(C1c3cc(C(=O)O)cc(O)c3C(=O)c3c(OC4OC(CO)C(O)C(O)C4O)cccc31)c1cccc(OC3OC(CO)C(O)C(O)C3O)c1C2=O","inchiKey":"IPQVTOJGNYVQEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL54481","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["555084","555085"],"drugbank":["DB11365"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559180","canonicalSmiles":"CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl","inchiKey":"QVPSGVSNYPRFAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOXSUPRINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1197051","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Defencin","Duvadilan","Duvadilan ret","Vasodilan"],"synonyms":["Isoxsuprine hydrochloride"],"crossReferences":{"PubChem":["144204018","170465968","26748094","56422878","855622"]},"count":1,"linkedTargets":{"rows":["ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":4},"linkedDiseases":{"rows":["EFO_0003885"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL559288","canonicalSmiles":"N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1","inchiKey":"IHEHEFLXQFOQJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRITRAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDS-NP-013","Pirinitramide","Piritramide","R 3365","R-3365"],"crossReferences":{"Wikipedia":["Piritramide"],"drugbank":["DB12492"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL583912","canonicalSmiles":"Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2","inchiKey":"PFTAWBLQPZVEMU-UKRRQHHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-EPICATECHIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-epicatechin","NSC-81161"],"crossReferences":{"PubChem":["11110917","11112309","11112310","144203652","170465932","50086732","81066101"],"drugbank":["DB12039"],"chEBI":["90"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL6685","canonicalSmiles":"NS(=O)(=O)c1nc2ccc(O)cc2s1","inchiKey":"NOOBQTYVTDBXTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL6685","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08765"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL689","canonicalSmiles":"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"FBPFZTCFMRRESA-KVTDHHQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANNITOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aridol kit","Bronchitol","Diosmol","Mannite","Mannitol","Osmitrol","Resectisol"],"synonyms":["Alexitol sodium","D-mannitol","E-421","E421","INS NO.421","INS-421","Isomalt impurity, mannitol-","Manna sugar","Mannite","Mannitol","NSC-407017"],"crossReferences":{"PubChem":["144205645","144208685","144210801","170465566","26757663","56322640"],"Wikipedia":["Mannitol"],"drugbank":["DB00742"],"chEBI":["16899"]},"count":26,"approvedIndications":["EFO_1000845","HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for brain edema and constipation and has 24 investigational indications."}
{"id":"CHEMBL6995","canonicalSmiles":"CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1","inchiKey":"DURULFYMVIFBIR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRACTOLOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eraldin"],"synonyms":["AY-21,011","I.C.I. 50,172","Practolol","[3-(4-Acetylamino-Phenoxy)-2-Hydroxy-Propyl]-Isopropyl-Ammonium"],"crossReferences":{"PubChem":["144204479","170466619","56463034"],"Wikipedia":["Practolol"],"drugbank":["DB01297"],"chEBI":["258351"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL70927","canonicalSmiles":"Cc1c(O)c(=O)ccn1C","inchiKey":"TZXKOCQBRNJULO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DEFERIPRONE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ferriprox"],"synonyms":["APO-066","APO-66","CP-20","CP20","DN-180-01-AF","DN-18001AF","Deferiprone","L-1","L1","PL-1","PL1"],"crossReferences":{"DailyMed":["deferiprone"],"PubChem":["104233432","144205982","26719648","26752603","8139956"],"Wikipedia":["Deferiprone"],"drugbank":["DB08826"],"chEBI":["68554"]},"count":11,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL8085","canonicalSmiles":"NCCCC[C@H](N)C(=O)O","inchiKey":"KDXKERNSBIXSRK-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LYSINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lysine"],"crossReferences":{"PubChem":["29218054"],"drugbank":["DB00123"],"chEBI":["18019"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL849","canonicalSmiles":"Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl","inchiKey":"XEFQLINVKFYRCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLOSAN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquasept","Gamophen","Innoxa","Manusept","Skinsan","Stri-dex cleansing bar","Stri-dex face wash","Tegusept"],"synonyms":["CH 3565","CH-3565","Cloxifenol","DNDI1246774","Triclosan"],"crossReferences":{"PubChem":["144205201","144214040","170464936","174006648","26754498","29215355","49674565","57260157"],"Wikipedia":["Triclosan"],"drugbank":["DB08604"],"chEBI":["164200"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 5 investigational indications."}
{"id":"CHEMBL9113","canonicalSmiles":"Cc1ccccc1","inchiKey":"YXFVVABEGXRONW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLUENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-406333","Toluene"],"crossReferences":{"PubChem":["17388690","17389706"],"Wikipedia":["Toluene"],"drugbank":["DB11558"],"chEBI":["17578"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL92361","canonicalSmiles":"O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12","inchiKey":"INSBKYCYLCEBOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CGP-029482","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP-029482"],"crossReferences":{"drugbank":["DB01765"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL934","canonicalSmiles":"CC(C)(C(=O)c1cccnc1)c1cccnc1","inchiKey":"FJLBFSROUSIWMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METYRAPONE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metopiron","Metopirone"],"synonyms":["Metyrapone","NSC-25265"],"crossReferences":{"DailyMed":["metyrapone"],"PubChem":["11112126","124881925","170465268","56323421"],"Wikipedia":["Metyrapone"],"drugbank":["DB01011"],"chEBI":["44241"]},"childChemblIds":["CHEMBL3989720"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 5 investigational indications."}
{"id":"CHEMBL941","canonicalSmiles":"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1","inchiKey":"KTUFNOKKBVMGRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMATINIB","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Gleevec","Imatinib","STI-571"],"crossReferences":{"DailyMed":["imatinib%20mesylate"],"PubChem":["103905596","124892207","124892208","124892209","26755316","29215405","50100104"],"Wikipedia":["Imatinib"],"drugbank":["DB00619"],"chEBI":["45783"]},"childChemblIds":["CHEMBL2386595","CHEMBL1642"],"count":44,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000157404","ENSG00000113721"],"count":3},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0001361","EFO_0004683","EFO_0000365","EFO_0007444","EFO_0000756","MONDO_0000956","EFO_1000657","EFO_1001919","EFO_0005952","EFO_0000497","EFO_0000333","EFO_1001951","EFO_0000565","Orphanet_178","EFO_0000339","EFO_0000588","EFO_0000389","MONDO_0008903","EFO_1001814","EFO_0000641","EFO_0000760","EFO_0004288","MONDO_0002715","MONDO_0013730","EFO_0002618","MONDO_0007608","MONDO_0005149","EFO_0000220","MONDO_0002108","EFO_0001642","MONDO_0008170","EFO_0000349","EFO_0005842","Orphanet_636","Orphanet_3389","EFO_1001946","MONDO_0044881","EFO_0002429","MONDO_0008315","Orphanet_398934","EFO_1000576","EFO_0003032","MONDO_0100096","MONDO_0000544","EFO_0000270","MONDO_0044917","EFO_0001359","EFO_0002428","EFO_0000574","EFO_1000613","EFO_0001376","EFO_0004610","Orphanet_232","MONDO_0015686","EFO_0000768","EFO_1001465","MONDO_0007254","EFO_0002087","MONDO_0021063","Orphanet_538","HP_0001880","MONDO_0003541","MONDO_0002087","EFO_0000209","EFO_0002430","MONDO_0001056","MONDO_0002158","Orphanet_31112","EFO_0000712","EFO_0004289","EFO_0000673","EFO_1001361","EFO_1001993","MONDO_0020743","EFO_0000717","MONDO_0002618","EFO_0002617","EFO_1000158","EFO_0002914","EFO_0000616","EFO_0003897","EFO_0000685","EFO_0006859","EFO_0000503","Orphanet_44890","MONDO_0016586","EFO_0000222","EFO_0000313","MONDO_0000870","MONDO_0003865","EFO_0003060","EFO_0000311","EFO_0003885","MONDO_0002676","EFO_1001471","EFO_0006861","EFO_0000658","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0002367","EFO_1000895","EFO_1001467","MONDO_0024880","EFO_0000691","MONDO_0004643","EFO_0000519","EFO_0003956","Orphanet_31837"],"count":110},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for cancer and neoplasm and has 42 investigational indications."}
{"id":"CHEMBL9940","canonicalSmiles":"CN(C)CCNC(=O)c1cccc2cc3ccccc3nc12","inchiKey":"XBGNERSKEKDZDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSC-601316","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-601316"],"crossReferences":{"drugbank":["DB11880"]},"childChemblIds":["CHEMBL1204136"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
